Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2021

Open Access 01-12-2021 | Lymphoma | Case report

Diagnosis and treatment of primary central nervous system lymphoma with the primary lesion in the hypothalamus: a case report

Authors: Ken Takao, Ayaka Tani, Tetsuya Suwa, Yayoi Kuwabara-Ohmura, Kenta Nonomura, Yanyan Liu, Takehiro Kato, Masami Mizuno, Takuo Hirota, Mayumi Enya, Katsumi Iizuka, Yukio Horikawa, Chiemi Saigo, Yusuke Kito, Tatsuhiko Miyazaki, Naoyuki Ohe, Toru Iwama, Daisuke Yabe

Published in: BMC Endocrine Disorders | Issue 1/2021

Login to get access

Abstract

Background

Primary central nervous system lymphoma is a rare extra-nodal lymphoma of the central nervous system. Primary central nervous system lymphoma lesions usually appear in the vicinity of the ventricle, and there are few reports of primary central nervous system lymphoma with hypothalamic-pituitary lesions.

Case presentation

We treated a 56-year-old male with primary central nervous system lymphoma with the primary lesion in the hypothalamus, which was found by magnetic resonance imaging after sudden onset of endocrinological abnormalities. Initially, he was hospitalized to our department for hyponatremia. Endocrinological examination in conjunction with head magnetic resonance imaging and endoscopic biopsy revealed hypothalamic hypopituitarism and tertiary hypoadrenocorticism caused by a rapidly growing, diffuse large B-cell lymphoma in the hypothalamus. Remission of the tumor was achieved by high-dose methotrexate with whole brain radiotherapy, and some of the hormone responses were normalized.

Conclusions

While primary central nervous system lymphoma is rare, it is important to note that hypopituitarism can result and that the endocrinological abnormalities can be partially restored by its remission.
Literature
1.
go back to reference Grommes C, DeAngelis LM. Primary CNS lymphoma. J Clin Oncol. 2017;35(21):2410–8.CrossRef Grommes C, DeAngelis LM. Primary CNS lymphoma. J Clin Oncol. 2017;35(21):2410–8.CrossRef
2.
go back to reference Brain Tumor Registry of Japan (2005–2008). Neurol Med Chir (Tokyo). 2017;57(Suppl 1):9–102. Brain Tumor Registry of Japan (2005–2008). Neurol Med Chir (Tokyo). 2017;57(Suppl 1):9–102.
3.
go back to reference DeWitt JC, Mock A, Louis DN. The 2016 WHO classification of central nervous system tumors: what neurologists need to know. Curr Opin Neurol. 2017;30(6):643–9.CrossRef DeWitt JC, Mock A, Louis DN. The 2016 WHO classification of central nervous system tumors: what neurologists need to know. Curr Opin Neurol. 2017;30(6):643–9.CrossRef
4.
go back to reference Brandsma D, Bromberg JEC. Primary CNS lymphoma in HIV infection. Handb Clin Neurol. 2018;152:177–86.CrossRef Brandsma D, Bromberg JEC. Primary CNS lymphoma in HIV infection. Handb Clin Neurol. 2018;152:177–86.CrossRef
5.
go back to reference Li L, Rong JH, Feng J. Neuroradiological features of lymphomatosis cerebri: a systematic review of the English literature with a new case report. Oncol Lett. 2018;16(2):1463–74.PubMedPubMedCentral Li L, Rong JH, Feng J. Neuroradiological features of lymphomatosis cerebri: a systematic review of the English literature with a new case report. Oncol Lett. 2018;16(2):1463–74.PubMedPubMedCentral
6.
go back to reference Tanki HN, Malik KN, Makhdoomi R, Feroz S, Ramzan AU. Primary hypothalamic lymphoma in an adult male: a case report and literature review. Oman Med J. 2018;33(4):346–51.CrossRef Tanki HN, Malik KN, Makhdoomi R, Feroz S, Ramzan AU. Primary hypothalamic lymphoma in an adult male: a case report and literature review. Oman Med J. 2018;33(4):346–51.CrossRef
7.
go back to reference Kuker W, Nagele T, Korfel A, Heckl S, Thiel E, et al. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neuro-Oncol. 2005;72(2):169–77.CrossRef Kuker W, Nagele T, Korfel A, Heckl S, Thiel E, et al. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neuro-Oncol. 2005;72(2):169–77.CrossRef
8.
go back to reference Giustina A, Gola M, Doga M, Rosei EA. Clinical review 136: primary lymphoma of the pituitary: an emerging clinical entity. J Clin Endocrinol Metab. 2001;86(10):4567–75.CrossRef Giustina A, Gola M, Doga M, Rosei EA. Clinical review 136: primary lymphoma of the pituitary: an emerging clinical entity. J Clin Endocrinol Metab. 2001;86(10):4567–75.CrossRef
9.
go back to reference Villano JL, Koshy M, Shaikh H, Dolecek TA, McCarthy BJ. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer. 2011;105(9):1414–8.CrossRef Villano JL, Koshy M, Shaikh H, Dolecek TA, McCarthy BJ. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma. Br J Cancer. 2011;105(9):1414–8.CrossRef
10.
go back to reference Su L, Ding M, Chen L, Li C, Lao M. Primary central nervous system lymphoma in a patient with systemic lupus erythematosus mimicking high-grade glioma: a case report and review of literature. Medicine (Baltimore). 2018;97(23):e11072.CrossRef Su L, Ding M, Chen L, Li C, Lao M. Primary central nervous system lymphoma in a patient with systemic lupus erythematosus mimicking high-grade glioma: a case report and review of literature. Medicine (Baltimore). 2018;97(23):e11072.CrossRef
11.
go back to reference Tsang M, Cleveland J, Rubenstein JL. On point in primary CNS lymphoma. Hematol Oncol. 2000;38(5):640–7.CrossRef Tsang M, Cleveland J, Rubenstein JL. On point in primary CNS lymphoma. Hematol Oncol. 2000;38(5):640–7.CrossRef
Metadata
Title
Diagnosis and treatment of primary central nervous system lymphoma with the primary lesion in the hypothalamus: a case report
Authors
Ken Takao
Ayaka Tani
Tetsuya Suwa
Yayoi Kuwabara-Ohmura
Kenta Nonomura
Yanyan Liu
Takehiro Kato
Masami Mizuno
Takuo Hirota
Mayumi Enya
Katsumi Iizuka
Yukio Horikawa
Chiemi Saigo
Yusuke Kito
Tatsuhiko Miyazaki
Naoyuki Ohe
Toru Iwama
Daisuke Yabe
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2021
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-020-00675-5

Other articles of this Issue 1/2021

BMC Endocrine Disorders 1/2021 Go to the issue